|Name||Tissue||Type of pathologies|
|Acute and chronic muscle aches and pain||Muscle||Pain management|
|Acute and chronic cervical and lumbar pain||Muscle||Idiopathic cervical and low back pain|
|Acute and chronic soft tissue wounds||Skin||Wounds|
|Calcifying tendinitis of the shoulder||Tendons||Tendinopathy|
|Chronic distal biceps tendinopathy||Tendons||Tendinopathy|
|Chronic proximal hamstring tendinopathy||Tendons||Tendinopathy|
|Diseases secondary to trigger points and myofascial Pain||Muscle||Myofascial pain syndrome|
|Greater trochanteric pain syndrome||Tendons||Tendinopathy|
|Insertional Achilles tendinopathy||Tendons||Tendinopathy|
|Medial tibial stress syndrome||Tendons||Tendinopathy|
|Mid-body Achilles tendinopathy||Tendons||Tendinopathy|
|Osgood-Schlatter disease||Bone||Disturbance of musculoskeletal development|
|Patella tip syndrome||Tendons||Tendinopathy|
|Primary and secondary lymphedema||Skin||Lymphedema|
|Primary long bicipital tenosynovitis||Tendons||Tendinitis|
|Proliferative connective tissue disorders||Connective tissue||Fibrosis|
|Spasticity||Central nervous system||Cerebral palsy and stroke|
|Subacromial pain syndrome||Tendons||Tendinopathy|
|Trigger points||Muscle||Myofascial pain syndrome|
Cellulite is defined as a localized metabolic disorder of subcutaneous tissue.
The main clinical symptom is a modification of the topography of the skin characterized by skin dimpling and nodularity. Diagnosis is based on the clinical features of the disease. At the microscopic level, cellulite presents with herniation of subcutaneous fat with fibrous connective tissue, leading to an orange peel-like or padded appearance of the skin.
The condition occurs mainly in postpubertal women on the pelvic region, lower limbs and the abdomen, and is divided in four stages.
The first stage affects the microcirculation of the skin, with no superficial changes observed.
During the second stage (secretion stage) the vasodilation is converted into the release of liquids to the extracellular space, and the skin starts to develop an orange peel-like texture.
The third stage (fibrosing stage) is characterized by an increase in number and size of adipose cells which form micronodules (cluster). The hypodermal septa thicken and become turgid. The spongy appearance of the skin becomes obvious in a lying position.
The fourth stage (sclerosis stage) can be seen as aggravation of the fibrosing stage, with the hypodermal septa becoming harder and further thickening. The irregularities, depressions and protrusions of the skin are visible to the naked eye.
The etiology of cellulite is multifactorial, with the following factors playing important roles:
(i) genetic predisposition;
(ii) gender (females >>males);
(iii) ethnicity (caucasians >> Asian women);
(iv) lifestyle (an excessive, high-carbohydrate diet results in hyperinsulinemia, promoting lipogenesis; and prolonged periods of sitting and/or standing may cause alterations in the microcirculation of cellulite prone areas); and
Additional factors are localized tissue vascularity, hormonal influences, and postinflammatory changes. However, the actual differences between the pathophysiology of cellulite and ‘‘normal’’ fat are largely unknown.
Approximately 85-98% of all postpubertal females display some degree of cellulite, without definite explanation for its presentation. Nevertheless, affected women seem to have fewer and mostly perpendicular hypodermal fibrous septae, whereas these septae are more and arranged in a “criss-cross” pattern in unaffected men and women.
Various treatments for cellulite have been developed, such as (in order of decreasing evidence-based medicine [EbM] level*): laser-assisted lipolysis (EbM level I-A), topical phosphatidylcholine and LED (I-A), endermology (II-A), radiofrequency (II-A), topical herbs and retinol (II-A), ultrasound (II-A), carboxy therapy (II-B), mesotherapy (II-B), weight loss (II-B), liposuction (III), cryolipolysis (IV), and subcision (IV). Radial shock wave therapy (RSWT) has been demonstrated being efficient for cellulite stages II and III (EbM level IIB), with improvement by approximately one stage for several months.
*Level IA: evidence from metaanalysis of randomized controlled trials.
Level IB: evidence from at least one randomized controlled trial.
Level IIA: evidence from at least one controlled study without randomization.
Level IIB: evidence from at least one other type of experimental study.
Level III: evidence from nonexperimental descriptive studies, such as comparative studies, correlation studies, and case control studies
Level IV: evidence from expert committee reports or opinions or clinical experience of respected authorities, or both.
Schlaudraff et al., Clin Cosmet Investig Dermatol 2014;7:171-183.
Predictability of the individual clinical outcome of extracorporeal shock wave therapy for celluliteREAD ABSTRACT
|Number of treatment sessions||8|
|Interval between two sessions||2 times a week|
|Air pressure Evo Blue®||3 to 4 bar|
|Air pressure Power+||2.5 to 4 bar|
|Impulses||200 - 300 impulses / cm2|
|Frequency||12Hz to 20Hz|
I agree that E.M.S. Electro Medical Systems S.A., with registered office at Che. de la Vuarpillière 31, CH 1260-Nyon, collects the personal information that I have filled in above. These information will be used to provide me with the services requested above.
I would like to receive quarterly newsletters of E.M.S. Electro Medical Systems S.A. by email with updates about its medical products, and the SDCA. I understand that my data will be used in order to receive marketing information and will not be forwarded to third parties. I can revoke my consent at any time by sending an email to firstname.lastname@example.org with effect for the future, or by clicking on the unsubscribe link on each email.